| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |